Tromsø

WP4: Advancing oncological PET imaging using machine learning

10. September 2020

The work package on machine learning will develop data analysis methods in support of the other work packages. The aim is to use expertise in artificial intelligence to help solving…

Read More

WP3: Phagocyte targeting in breast cancer

10. September 2020

In spite of an enormous global research effort, astonishing preclinical cancer cures, and the approval of multiple formulations, nanomedicine’s impact on cancer patient care remains limited. Recently, it is becoming…

Read More

WP2: Radionuclide targeted therapy and imaging in Glioblastoma

10. September 2020

The plasticity of GB tumor cells and their ability to infiltrate adjoining brain tissue limits the effectiveness of current cancer therapies. Microglia plays an important role in GB progression. Inhibition…

Read More

WP1: Immuno-PET and lung cancer

10. September 2020

Despite the demonstrated effectiveness of immunoregulatory agents such as immune checkpoint blockers (ICB) on refractory cancers, these therapies work satisfactorily only in a reduced subset of patients. Further, ICB treatments…

Read More